.png)
Digital Health PR
Series C Spotlight: Buoy Health’s $38M Funding Announcement Breakthrough
The $38M Series C announcement secured tier-1 healthcare and business media coverage, ensuring investor, enterprise, and healthcare stakeholder visibility during one of the most competitive news cycles in digital health history.
Campaign messaging consistently tied the funding to measurable real-world adoption—highlighting Buoy’s support of more than 1M users and reinforcing validation from strategic investors Cigna Ventures, Humana, and Optum Ventures.
Executive positioning in Business Insider and Fierce Healthcare elevated Buoy beyond a funding event, establishing CEO Andrew Le as a credible voice on healthcare access trends and strengthening the company’s authority beyond the immediate pandemic context.
THE
CHALLENGE
In 2020, Buoy Health needed to announce a $38 million Series C funding round at the height of the COVID-19 pandemic—an environment defined by unprecedented demand for digital health solutions and intense competition for media attention.
The funding round included strategic investors Cigna Ventures, Humana, and Optum Ventures, signaling strong enterprise validation. The challenge was to communicate this milestone in a way that cut through pandemic saturation coverage while positioning Buoy not only as a crisis-response solution, but as a durable platform for long-term healthcare access.
Society22 PR was engaged to secure high-impact media coverage, elevate executive credibility, and frame the funding as proof of both immediate relevance and sustained market value.
.png)
THE SOCIETY22
APPROACH
The communications strategy focused on contextual relevance, credibility, and executive storytelling.
Pandemic-driven narrative positioning
Society22 PR positioned Buoy Health as an essential infrastructure solution during a national healthcare access crisis. By late 2020, more than 1 million Americans had used Buoy’s AI-powered symptom checker to navigate care decisions at a time when patients were avoiding emergency rooms and delaying treatment.
Rather than isolating the funding as a financial event, the narrative connected investment momentum to Buoy’s real-world impact during COVID-19—framing the raise as validation of urgent market need.
Executive thought leadership
CEO Andrew Le was positioned as a credible voice on the downstream effects of the pandemic on healthcare utilization. Commentary focused on declining emergency room visits for serious conditions and the role technology could play in guiding patients to appropriate care.
This approach ensured Buoy was featured not only as a funded company, but as a trusted authority on healthcare access during crisis conditions.
Strategic investor signaling
Messaging emphasized the strategic nature of the funding round, highlighting participation from Cigna, Humana, and Optum Ventures. Coverage reinforced Buoy’s enterprise credibility and positioned the platform as aligned with major healthcare stakeholders.
THE
RESULTS
2020 media coverage
Society22 PR secured high-impact placements across healthcare and business media:
Fierce Healthcare featured the Series C announcement, highlighting Buoy’s role in AI-powered symptom triage during the pandemic and reaching healthcare executives, payers, and enterprise decision-makers
Business Insider published a CEO feature profiling Andrew Le’s founding story and commentary on pandemic-driven healthcare access challenges
Business Insider also covered Buoy’s funding round and pitch deck, detailing the $38M raise and strategic investor participation
These placements ensured visibility across investor, enterprise, and healthcare stakeholder audiences.
Messaging pull-through
Coverage consistently reinforced four core narratives:
Buoy as a pandemic-response leader supporting more than 1M users
Enterprise validation through strategic healthcare investors
Technology-driven solutions addressing patient fear and access barriers
Long-term platform relevance beyond COVID-19
The Impact
The campaign supported Buoy Health during a pivotal growth moment by translating pandemic relevance into long-term credibility.
Media coverage coincided with the successful close of the $38M Series C round, elevated Buoy’s profile among enterprise healthcare organizations, and reinforced trust in the platform during a period of national uncertainty.
By anchoring the funding announcement in real-world impact and executive authority, Society22 PR ensured Buoy’s story stood out amid pandemic noise—positioning the company as both timely and enduring.